Literature DB >> 17679925

Adaptive trial design.

Donald A Berry1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17679925

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  7 in total

Review 1.  The future of drug development: advancing clinical trial design.

Authors:  John Orloff; Frank Douglas; Jose Pinheiro; Susan Levinson; Michael Branson; Pravin Chaturvedi; Ene Ette; Paul Gallo; Gigi Hirsch; Cyrus Mehta; Nitin Patel; Sameer Sabir; Stacy Springs; Donald Stanski; Matthias R Evers; Edd Fleming; Navjot Singh; Tony Tramontin; Howard Golub
Journal:  Nat Rev Drug Discov       Date:  2009-10-09       Impact factor: 84.694

2.  Bayesian adaptive randomization designs for targeted agent development.

Authors:  J Jack Lee
Journal:  Clin Trials       Date:  2010-06-22       Impact factor: 2.486

Review 3.  Bayesian clinical trials in action.

Authors:  J Jack Lee; Caleb T Chu
Journal:  Stat Med       Date:  2012-06-18       Impact factor: 2.373

4.  New considerations in the design of clinical trials for the treatment of acute leukemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Clin Investig (Lond)       Date:  2011-04-01

Review 5.  An integrative paradigm to impart quality to correlative science.

Authors:  Michael Kalos
Journal:  J Transl Med       Date:  2010-03-16       Impact factor: 5.531

6.  Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine.

Authors:  Xian Zhou; Suyu Liu; Edward S Kim; Roy S Herbst; J Jack Lee
Journal:  Clin Trials       Date:  2008       Impact factor: 2.486

7.  Adaptive trial design: could we use this approach to improve clinical trials in the field of global health?

Authors:  Trudie Lang
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.